Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 ROS1 rearrangements in lung cancer: a new genomic subset of lung adenocarcinoma.

Literature DB >> 22215755

ROS1 rearrangements in lung cancer: a new genomic subset of lung adenocarcinoma.

Pasi A Jänne, Matthew Meyerson.

Abstract

Entities: Disease Gene

Mesh：

Substances：

Year: 2012 PMID： 22215755 DOI： 10.1200/JCO.2011.39.4197

Source DB: PubMed Journal: J Clin Oncol ISSN： 0732-183X Impact factor: 44.544

Keyword Cloud
Cited

× No keyword cloud information.

15 in total

1. Diagnosis of lung cancer in small biopsies and cytology: implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification.

Authors: William D Travis; Elisabeth Brambilla; Masayuki Noguchi; Andrew G Nicholson; Kim Geisinger; Yasushi Yatabe; Yuichi Ishikawa; Ignacio Wistuba; Douglas B Flieder; Wilbur Franklin; Adi Gazdar; Philip S Hasleton; Douglas W Henderson; Keith M Kerr; Iver Petersen; Victor Roggli; Erik Thunnissen; Ming Tsao
Journal: Arch Pathol Lab Med Date: 2012-09-12 Impact factor: 5.534

Review 2. Molecular testing in lung cancer in the era of precision medicine.

Authors: Helmut H Popper; Ales Ryska; József Tímár; Wlodzimierz Olszewski
Journal: Transl Lung Cancer Res Date: 2014-10

3. The oncogenic lung cancer fusion kinase CD74-ROS activates a novel invasiveness pathway through E-Syt1 phosphorylation.

Authors: Hyun Jung Jun; Hannah Johnson; Roderick T Bronson; Sebastien de Feraudy; Forest White; Alain Charest
Journal: Cancer Res Date: 2012-06-01 Impact factor: 12.701

Review 4. Chemoradiation for definitive, preoperative, or postoperative therapy of locally advanced non-small cell lung cancer.

Authors: Josephine Feliciano; Steven Feigenberg; Minesh Mehta
Journal: Cancer J Date: 2013 May-Jun Impact factor: 3.360

Review 5. Novel targets in non-small cell lung cancer: ROS1 and RET fusions.

Authors: Justin F Gainor; Alice T Shaw
Journal: Oncologist Date: 2013-06-28

6. Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology.

Authors: Neal I Lindeman; Philip T Cagle; Mary Beth Beasley; Dhananjay Arun Chitale; Sanja Dacic; Giuseppe Giaccone; Robert Brian Jenkins; David J Kwiatkowski; Juan-Sebastian Saldivar; Jeremy Squire; Erik Thunnissen; Marc Ladanyi
Journal: J Thorac Oncol Date: 2013-07 Impact factor: 15.609

7. Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology.